Friess Lab

Advancing neuroprotective therapies for traumatic brain injury, our laboratory uses clinically relevant animal models to study the impact of secondary insults such as intracranial hypertension, hypoxemia and neuroinflammation following moderate and severe TBI. By uncovering how these factors influence recovery, we aim to develop innovative neuroprotective strategies and therapeutics that improve outcomes for patients with traumatic brain injury.